Five siRNAs Targeting Three SNPs May Provide Therapy for Three-Quarters of Huntington's Disease Patients
Top Cited Papers
Open Access
- 9 April 2009
- journal article
- other
- Published by Elsevier in Current Biology
- Vol. 19 (9) , 774-778
- https://doi.org/10.1016/j.cub.2009.03.030
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficitsProceedings of the National Academy of Sciences, 2007
- Allele-specific RNAi selectively silences mutant SOD1 and achieves significant therapeutic benefit in vivoNeurobiology of Disease, 2006
- rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouseBiochemical and Biophysical Research Communications, 2006
- Clinico-pathological rescue of a model mouse of Huntington's disease by siRNANeuroscience Research, 2005
- RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse modelProceedings of the National Academy of Sciences, 2005
- Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALSNature Medicine, 2005
- Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS modelNature Medicine, 2005
- RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxiaNature Medicine, 2004
- siRNA-mediated gene silencing in vitro and in vivoNature Biotechnology, 2002
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993